Latest Metapneumovirus Stories

2011-07-19 15:05:00

AUSTIN, Texas, July 19, 2011 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its xTAG Respiratory Viral Panel FAST (RVP FAST). This front line test has the potential to significantly change the way respiratory viral testing is performed and complements the company's existing respiratory portfolio. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Laboratories and...

2010-05-26 13:34:14

Researchers at the University of Warwick, and the Kenya Medical Research Institute, Kilifi, Kenya, have found that respiratory syncytial virus (RSV) appears to be the predominant virus detected among infants and children hospitalized in Kenya with severe pneumonia, according to a study in the May 26 issue of JAMA. The contribution to this severe disease by an individual pathogen stresses the need for effective infant vaccination. The leading cause of childhood death in sub-Saharan Africa is...

2009-11-24 15:01:00

SAN DIEGO, Nov. 24 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the US Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProParaflu+(TM) assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections. Prodesse is a wholly-owned subsidiary of Gen-Probe, a global leader in molecular diagnostics. "FDA clearance of our 510(k) application for ProParaflu+...

2009-10-22 15:01:00

SAN DIEGO, Oct. 22 /PRNewswire-FirstCall/ -- Gen-Probe (Nasdaq: GPRO) announced today that the Company has completed its acquisition of Prodesse, Inc., a leader in molecular testing for influenza and other infectious diseases, for approximately $60 million in cash. Gen-Probe's purchase price could increase to up to $85 million if Prodesse achieves certain financial and regulatory milestones in 2010 and 2011. "We are delighted to complete this acquisition ahead of schedule and...

2009-02-05 14:33:50

U.S. researchers said on Wednesday that a highly contagious respiratory virus is far more widespread among children than once thought and puts more of them in the hospital than influenza. The respiratory syncytial virus, known as RSV, affects 2.1 million children under the age of 5 each year. Dr. Caroline Breese Hall of the University of Rochester Medical Center in New York discovered that over the last four years, the virus was responsible for 20 percent of hospitalizations, 18 percent of...

2008-11-20 12:00:00

A virus that causes cold-like symptoms in humans originated in birds and may have crossed the species barrier around 200 years ago, according to an article published in the December issue of the Journal of General Virology. Scientists hope their findings will help us understand how potentially deadly viruses emerge in humans."Human metapneumovirus may be the second most common cause of lower respiratory infection in young children. Studies have shown that by the age of five, virtually all...

2008-10-16 15:00:27

Diagnostic HYBRIDS announces the release of its D3(R) Ultra 8(TM) DFA Respiratory Virus Screening & Identification Kit for the Canadian market. Ultra 8 is the only commercially available monoclonal antibody blend that detects and identifies eight major respiratory viruses - including human metapneumovirus - in direct patient specimens and cell culture by immunofluorescence. Direct specimen results are available in as little as 15-30 minutes. When combined with the patented Diagnostic...

2008-10-08 09:00:50

Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has received clearance from Health Canada for its xTAG(TM) Respiratory Viral Panel (RVP). xTAG RVP is a unique, groundbreaking test that, from one patient sample, simultaneously detects the 18 respiratory viruses and subtypes that are responsible for the majority of respiratory viral infections. As many as 80 percent of respiratory infections are caused by viruses, yet these viruses...

2008-07-14 15:00:52

Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, and ViroNovative BV today announced that the companies have signed a licensing agreement that gives Luminex worldwide rights to use ViroNovative's human metapneumovirus (hMPV) intellectual property in the xTAG Respiratory Viral Panel (RVP). Under the terms of the agreement, rights to ViroNovative's hMPV intellectual property will be extended to Luminex's distributors and end-user customers around the world....

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'